|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,960,592 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,960,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-61.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-24 |
4 |
AS |
$76.30 |
$90,110 |
D/D |
(1,181) |
61,439 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-05-13 |
4 |
AS |
$69.26 |
$86,431 |
D/D |
(1,248) |
7,270 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Officer |
|
2016-03-04 |
4 |
AS |
$88.42 |
$110,970 |
D/D |
(1,255) |
46,882 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-16 |
4 |
D |
$77.21 |
$99,369 |
D/D |
(1,287) |
65,441 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-16 |
4 |
D |
$80.72 |
$103,887 |
D/D |
(1,287) |
67,458 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-18 |
4 |
AS |
$77.99 |
$102,011 |
D/D |
(1,308) |
64,133 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-05-26 |
4 |
AS |
$78.94 |
$103,254 |
D/D |
(1,308) |
54,109 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-06-04 |
4 |
AS |
$122.35 |
$166,646 |
D/D |
(1,362) |
35,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-30 |
4 |
AS |
$79.56 |
$109,872 |
D/D |
(1,381) |
56,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$130,187 |
D/D |
(1,414) |
51,571 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-11 |
4 |
AS |
$90.31 |
$129,685 |
D/D |
(1,436) |
50,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-06-04 |
4 |
D |
$120.46 |
$179,244 |
D/D |
(1,488) |
36,967 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$133,920 |
D/D |
(1,488) |
59,809 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$134,991 |
D/D |
(1,488) |
48,948 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-22 |
4 |
D |
$78.52 |
$118,801 |
D/D |
(1,513) |
62,620 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-29 |
4 |
AS |
$79.69 |
$122,484 |
D/D |
(1,537) |
55,033 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-04-01 |
4 |
AS |
$82.00 |
$126,034 |
D/D |
(1,537) |
65,471 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-04-08 |
4 |
AS |
$78.81 |
$121,131 |
D/D |
(1,537) |
58,250 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-02 |
4 |
D |
$79.86 |
$128,894 |
D/D |
(1,614) |
58,304 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-25 |
4 |
AS |
$78.47 |
$126,964 |
D/D |
(1,618) |
67,008 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-29 |
4 |
AS |
$79.43 |
$128,518 |
D/D |
(1,618) |
57,638 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-05-26 |
4 |
AS |
$126.55 |
$205,647 |
D/D |
(1,625) |
39,245 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-30 |
4 |
AS |
$74.79 |
$123,553 |
D/D |
(1,652) |
59,787 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$164,319 |
D/D |
(1,749) |
51,510 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-24 |
4 |
AS |
$74.36 |
$151,769 |
D/D |
(2,041) |
68,626 |
0 |
- |
|
174 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|